Tyrosine Kinase Signaling Pathways Modulate Angiotensin II-Induced Calcium ([Ca2+]1) Transients in Vascular Smooth Muscle Cells

Hypertension

Volumn 27, Issue 5, 1996, Pages 1097-1103

  Touyz, R M ^a   Schiffrin, E L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Angiotensin II; Calcium; Insulin; Muscle, smooth, vascular; Platelet derived growth factor; Protein tyrosine kinase

Indexed keywords

ANGIOTENSIN; CALCIUM ION; GENISTEIN; INSULIN; PHOSPHOLIPASE C; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; DRUG EFFECT; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CALCIUM; GENISTEIN; GROWTH SUBSTANCES; INSULIN; INTRACELLULAR MEMBRANES; ISOFLAVONES; MALE; MUSCLE, SMOOTH, VASCULAR; OSMOLAR CONCENTRATION; PROTEIN-TYROSINE KINASES; RATS; RATS, INBRED WKY; SIGNAL TRANSDUCTION;

EID: 0029874358     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.5.1097     Document Type: Article

References (47)

1. Rembold CM. Regulation of contraction and relaxation in arterial smooth muscle. Hypertension. 1992;20:129-137.
2. Hathaway DR, March KL, Lash JA, Adam LP, Wilensky RL. Vascular smooth muscle: a review of the molecular basis of contractility. Circulation. 1991;83:382-390.
3. Wang JYJ, McWhirter JR. Tyrosine kinase dependent signaling pathways. Trends Cardiovasc Med. 1994;4:264-270.
4. Tsuda T, Kawahara Y, Shii K, Koide M, Ishida Y, Yokohama M. Vasoconstrictor induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett. 1991;285:44-48.
5. Berridge MJ. Inositol trisphosphate and calcium signaling. Nature. 1993;361:315-361.
6. Force T, Kyriakis JM, Avruch J, Bonventre JV. Enclothelin, vasopressin and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. J Biol Chem. 1991;266:6650-6656.
7. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 1993;268: 7338-7348.
8. Huckle WR, Dy RC, Earp HS. Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II. Proc Natl Acad Sci U S A. 1992;89:8837-8841.
9. Granot Y, Erikson E, Fridman H. Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured vascular smooth muscle cells. J Biol Chan. 1993;268:9564-9569.
10. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun. 1993;190: 968-974.
11. Toma CT, Jensen PE, Prieto D, Hughes A, Mulvany M, Aalkjaer C. Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries. Br J Pharmacol. 1995;114:1266-1272.
12. 2+ in rabbit isolated ear artery by platelet-derived growth factor. Br J Pharm. 1995;114:138-142.
13. 2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture: actions of tyrosine kinase. J Biol Chem. 1994;269:9011-9018.
14. Touyz RM, Tolloczko B, Schiffrin EL. Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells. Hypertension. 1994;23(suppl I):I-23-I-28.
15. Clapham DE. Calcium signaling. Cell. 1995;80:259-268.
16. Wijetunge S, Aalkjaer C, Schachter M, Hughes A. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun. 1992;189:1620-1623.
17. Nilson H, Jensen PE, Mulvany M. Minor role for direct adrenoceptor-mediated calcium entry in rat mesenteric small arteries. J Vasc Res. 1994;31:314-321.
18. Weiss RH, Nuccitelli R. Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, hut not intracellular free calcium release in vascular smooth muscle cells. J Biol Chem. 1992; 267:5608-5613.
19. 2-adrenergic receptors in response to insulin. J Biol Chem. 1992;267:26017-26022.
20. Port JD, Malbon CC. Integration of transmembrane signaling: cross talk among G-protein-linked receptors and other signal transduction pathways. Trends Cardiovasc Med. 1993;3:85-92.
21. Fujitani Y, Ninomiya H, Okada T, Urade Y, Masaki T. Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1 beta. J Clin Invest. 1995;95: 2474-2482.
22. Schiffrin EL, Poissant L, Cantin M, Thibault G. Receptors for atrial natriuretic factor in cultured vascular smooth muscle cells. Life Sci. 1986;38:817-826.
23. Touyz RM, Tolloczko B, Schiffrin EL. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1. J Hypertens. 1994;12:663-673.
24. Touyz RM, Larivière R, Schiffrin EL. Endothelin receptor subtypes in mesenteric vascular smooth muscle cells of SHR. Can J Physiol Pharmacol. 1995;73:1262-1273.
25. 2+ indicators with greatly improved fluorescent properties. J Biol Chem. 1985;260:3440-3450.
26. Lyall RM, Zilberstein A, Gazit A, Gilon C, Levitzki A, Schlessinger J. Tyrphostins inhibit epidermal growth factor (EFG)-receptor tyrosine kinase activity in living cells and EFG-stimulated cell proliferation. J Biol Chem. 1989;264:14503-14509.
27. Casnellie JE. Protein kinase inhibitors: probes for the functions of protein phosphorylation. Adv Pharmacol. 1991;22:167-205.
28. Hughes AD, Patel M, Wijetunge S, Clunn G, Schachter M. Comparison of effects of platelet-derived growth factor isoforms on signaling and DNA synthesis of human cultured saphenous vein cells. J Cardiovasc Pharm. 1995;25:481-485.
29. Mogami H, Kojima I. Stimulation of calcium entry is a prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem Biophys Res Commun. 1993; 196:650-658.
30. Hollenberg MD. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci. 1994;15:108-114.
31. Gan BS, MacConnell KL, Hollenberg MD. Epidermal growth factor-urogastrone causes vasodilation in the anesthetized dog. J Clin Invest. 1987;80:199-201.
32. 2+ transients by insulin in cultured unpassaged vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens. 1995;8:104-112.
33. Munzenmaier DH, Greene AS. Angiotensin II mediates a sustained rise in nuclear and cytoplasmic calcium via multiple receptor subtypes. Am J Physiol. 1995;269(part 2):H565-H570.
34. Smith JB. Angiotensin-receptor signaling in cultured vascular smooth muscle cells. Am J Physiol. 1986;250:F759-F769.
35. Standley PR, Zhang F, Ram JL. Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest. 1991;88: 1230-1236.
36. Wambach GK, Liu D. Insulin attenuates vasoconstriction by nor-adrenaline, serotonin and potassium chloride in rat mesenteric arterioles. Clin Exp Hypertens A. 1992;14:733-740.
37. Saito F, Hori MT, Fittingoff M. Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells. J Clin invest. 1993;92:1161-1167.
38. 2+ transport is altered in vascular smooth muscle cells of spontaneously hypertensive rats. Hypertension. 1994;23(part 2):931-935.
39. 2+-ATPase. Am J Hypertens. 1992;5:637-641.
40. Muramatsu I, Hollenberg MD, Lederis K. Vascular actions of epidermal growth factor-urogastrone: possible relationship to prostaglandin production. Can J Physiol Pharmacol. 1985;63:994-999.
41. 2+ pump of the plasma membrane. J Biol Chem. 1992;267:2115-2118.
42. Carafoli E, Guerini D. Molecular and cellular membrane calcium ATPase. Trends Cardiovasc Med. 1993;3:177-184.
43. Saad AH, Kuo SS, Koong AC, Hahn GM, Giaccia AJ. Modulation of potassium channels by protein tyrosine kinase inhibitors. J Cell Physiol. 1994;161:142-148.
44. Abler A, Smith JA, Randazzo PA, Rothenberg PL, Jarett L. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem. 1994;267:3946-3951.
45. Levitzki A, Gilon C. Tyrphostins as molecular tools and potential antiproliferative drugs. Trends Pharmacol Sci. 1991;12:171-174.
46. Yang S-G, Saifeddine M, Hollenberg MD. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle. Can J Physiol Pharmacol. 1992;70:85-93.
47. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-λ1 in vascular smooth muscle cells. J Biol Chem. 1994;269: 10935-10939.